Table 1.
Test group | Total number of sera tested | Number of sera reactive with epsilon toxin | Number of sera reactive with PA83 | Number of sera which did not react with PA83 | Sera reactive with epsilon toxin but not with PA83 |
|
---|---|---|---|---|---|---|
n | % | |||||
CDMS | 65 | 18 | 4 | 61 | 14 | 23 |
CDMS control | 65 | 7 | 2 | 63 | 5 | 8 |
CIS | 20 | 7 | 0 | 20 | 7 | 35 |
CIS control | 20 | 2 | 0 | 20 | 2 | 10 |
ON | 44 | 9 | 0 | 44 | 9 | 20 |
ON control | 44 | 8 | 2 | 42 | 6 | 14 |
Total CDMS/CIS/ON | 129 | 34 | 4 | 125 | 30 | 24 |
Total controls | 129 | 17 | 4 | 125 | 13 | 10 |
CDMS: clinically definite multiple sclerosis; CIS: clinically isolated syndrome; ON: optic neuritis.